DNA methylation represses the expression of the human erythropoietin gene by two different mechanisms

Blood

Volumn 95, Issue 1, 2000, Pages 111-119

  Yin, Hong ^a   Blanchard, K L ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; NUCLEAR PROTEIN;

ARTICLE; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

EID: 0033957513     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.1.111.001k20_111_119     Document Type: Article

References (75)

1. Swartz MN, Trautner TA, Kornberg A. Enzymatic synthesis of deoxyribonucleic acid. J Biol Chem. 1962;237:1961-1967.
2. Antequera F, Bird A. Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci U S A. 1993;90:11995-11999.
3. Antequera F, Bird A. Predicting the total number of human genes [letter; comment]. Nat Genet. 1994;8:114.
4. Cross SH, Bird AP. CpG islands and genes. Curr Opin Genet Dev. 1995;5:309-314.
5. Larsen F, Gundersen G, Lopez R, Prydz H. CpG islands as gene markers in the human genome. Genomics. 1992;13:1095-1107.
6. Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol. 1987;196:261-282.
7. Siegfried Z, Cedar H. DNA methylation: a molecular lock. Curr Biol. 1997;7:R305-307.
8. Naveh-Many T, Cedar H. Active gene sequences are undermethylated. Proc Natl Acad Sci U S A. 1981;78:4246-4250.
9. Meehan R, Lewis J, Cross S, Nan X, Jeppesen P, Bird A. Transcriptional repression by methylation of CpG. J Cell Sci. 1992;16(suppl):9-14.
10. Taylor SM, Jones PA. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell. 1979;17:771-779.
11. Harris M. Induction of thymidine kinase in enzyme-deficient Chinese hamster cells. Cell. 1982; 29:483-492.
12. Razin A, Shemer R. DNA methylation in early development. Hum Mol Genet. 1995;4:1751-1755.
13. Riggs AD, Pfeifer GP. X-chromosome inactivation and cell memory. Trends Genet. 1992;8:169-174.
14. Schroeder M, Mass MJ. CpG methylation inactivates the transcriptional activity of the promoter of the human p53 tumor suppressor gene. Biochem Biophys Res Commun. 1997;235:403-406.
15. Herman JG, Latif F, Weng Y, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A. 1994;91:9700-9704.
16. Herman JG, Merlo A, Mao L, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res. 1995;55:4525-4530.
17. Bird AP. The relationship of DNA methylation to cancer. Cancer Surv. 1996;28:87-101.
18. Stirzaker C, Millar DS, Paul CL, et al. Extensive DNA methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res. 1997;57: 2229-2237.
19. Lapidus RG, Ferguson AT, Ottaviano YL, et al. Methylation of estrogen and progesterone receptor gene 5′ CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors. Clin Cancer Res. 1996;2:805-810.
20. Rice JC, Massey-Brown KS, Futscher BW. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene. 1998;17:1807-1812.
21. Graff JR, Herman JG, Lapidus RG, et al. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 1995;55:5195-5199.
22. Bird AP. Gene number, noise reduction and biological complexity [see comments]. Trends Genet. 1995;11:94-100.
23. Hendrich B, Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol. 1998;18:6538-6547.
24. Meehan RR, Lewis JD, McKay S, Kleiner EL, Bird AP. Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell. 1989;58:499-507.
25. Boyes J, Bird A. Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein. EMBO J. 1992;11: 327-333.
26. Jones PL, Veenstra GJ, Wade PA, et al. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet. 1998;19:187-191.
27. Meehan RR, Lewis JD, Bird AP. Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucl Acids Res. 1992;20:5085-5092.
28. Nan X, Ng HH, Johnson CA, et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex [see comments]. Nature 1998;393:386-389.
29. Razin A. CpG methylation, chromatin structure and gene silencing: a three-way connection. EMBO J. 1998;17:4905-4908.
30. McArthur M, Thomas JO. A preference of histone H1 for methylated DNA. EMBO J. 1996;15:1705-1714.
31. Ball DJ, Gross DS, Garrard WT. 5-methylcytosine is localized in nucleosomes that contain histone H1. Proc Natl Acad Sci U S A. 1983;80:5490-5494.
32. Ratcliffe PJ, Jones RW, Phillips RE, Nicholls LG, Bell JI. Oxygen-dependent modulation of erythropoietin mRNA levels in isolated rat kidneys studied by RNAse protection. J Exp Med. 1990;172: 657-660.
33. Jacobson LO, Goldwasser E, Fried W, Pizak L. Role of the kidney in erythropoiesis. Nature (London) 1957;179:633-634.
34. Zanjani ED, Poster J, Burlington H, Mann LI, Wasserman LR. Liver as the primary site of erythropoietin formation in the fetus. J Lab Clin Med. 1977;89:640-644.
35. Eckardt KU, Pugh CW, Meier M, Tan CC, Ratcliffe PJ, Kurtz A. Production of erythropoietin by liver cells in vivo and in vitro. Ann N Y Acad Sci. 1994; 718:50-60.
36. Rich IN, Vogt C, Pentz S. Erythropoietin gene expression in vitro and in vivo detected by in situ hybridization. Blood Cells. 1988;14:505-520.
37. Stopka T, Zivny JH, Stopkova P, Prchal JF, Prchal JT. Human hematopoietic progenitors express erythropoietin. Blood. 1998;91:3766-3772.
38. Tan CC, Eckardt KU, Firth JD, Ratcliffe PJ. Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Am J Physiol. 1992;263:F474-481.
39. Gopfert T, Eckardt KU, Geb B, Kurtz A. Oxygen-dependent regulation of erythropoietin gene expression in rat hepatocytes. Kidney Int. 1997;51: 502-506.
40. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev. 1992;72: 449-489.
41. Semenza GL, Traystman MD, Gearhart JD, Antonarakis SE. Polycythemia in transgenic mice expressing the human erythropoietin gene. Proc Natl Acad Sci U S A. 1989;86:2301-2305.
42. Semenza GL, Koury ST, Nejfelt MK, Gearhart JD, Antonarakis SE. Cell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic mice. Proc Natl Acad Sci U S A. 1991;88:8725-8729.
43. Madan A, Lin C, Hatch SL II, Curtin PT. Regulated basal, inducible, and tissue-specific human erythropoietin gene expression in transgenic mice requires multiple cis DNA sequences. Blood. 1995; 85:2735-2741.
44. Loya F, Yang Y, Lin H, Goldwasser E, Albitar M. Transgenic mice carrying the erythropoietin gene promoter linked to lacZ express the reporter in proximal convoluted tubule cells after hypoxia. Blood. 1994;84:1831-1836.
45. Lacombe C, Da Silva JL, Bruneval P, et al. Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney. J Clin Invest. 1988; 81:620-623.
46. Koury ST, Bondurant MC, Semenza GL, Koury MJ. The use of in situ hybridization to study erythropoietin gene expression in murine kidney and liver. Microsc Res Tech. 1993;25:29-39.
47. Fisher JW, Koury S, Ducey T, Mendel S. Erythropoietin production by interstitial cells of hypoxic monkey kidneys. Br J Haematol. 1996;95:27-32.
48. Caro J, Zon LI, Silver R, Miller O, Erslev AJ. Erythropoietin in liver tissue extracts and in liver perfusates from hypoxic rats. Am J Physiol. 1983; 244:E431-434.
49. Maxwell PH, Ferguson DJ, Osmond MK, et al. Expression of a homologously recombined erythopoietin-SV40 T antigen fusion gene in mouse liver: evidence for erythropoietin production by Ito cells. Blood. 1994;84:1823-1830.
50. Goldberg MA, Glass GA, Cunningham JM, Bunn HF. The regulated expression of erythropoietin by two human hepatoma cell lines. Proc Natl Acad Sci U S A. 1987;84:7972-7976.
51. Goldberg MA, Gaut CC, Bunn HF. Erythropoietin mRNA levels are governed by both the rate of gene transcription and posttranscriptional events. Blood. 1991;77:271-277.
52. Fandrey J, Bunn HF. In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction. Blood. 1993;81:617-623.
53. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucl Acids Res. 1994;22:2990-2997.
54. Blanchard KL, Acquaviva AM, Galson DL, Bunn HF. Hypoxic induction of the human erythropoietin gene: cooperation between the promoter and enhancer, each of which contains steroid receptor response elements. Mol Cell Biol. 1992;12:5373-5385.
55. Pfeifer GP, Riggs AD. Chromatin differences between active and inactive X chromosomes revealed by genomic footprinting of permeabilized cells using DNase I and ligation-mediated PCR. Genes Dev. 1991;5:1102-1113.
56. Hu B, Wright E, Campbell L, Blanchard KL. In vivo analysis of DNA-protein interactions on the human erythropoietin enhancer. Mol Cell Biol. 1997;17:851-856.
57. Singal R, Ferris R, Little JA, Wang SZ, Ginder GD. Methylation of the minimal promoter of an embryonic globin gene silences transcription in primary erythroid cells. Proc Natl Acad Sci U S A. 1997;94:13724-13729.
58. Lewis JD, Meehan RR, Henzel WJ, et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell. 1992;69:905-914.
59. Gupta M, Goldwasser E. The role of the near upstream sequence in hypoxia-induced expression of the erythropoietin gene. Nucl Acids Res. 1996; 24:4768-4774.
60. Imagawa S, Yamamoto M, Miura Y. GATA transcription factors negatively regulate erythropoietin gene expression. Acta Haematol. 1996;95: 248-256.
61. Imagawa S, Yamamoto M, Miura Y. Negative regulation of the erythropoietin gene expression by the GATA transcription factors. Blood. 1997; 89:1430-1439.
62. Semenza GL, Nejfelt MK, Chi SM, Antonarakis SE. Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc Natl Acad Sci U S A. 1991; 88:5680-5684.
63. Wang GL, Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem. 1995;270:1230-1237.
64. Semenza GL, Jiang BH, Leung SW, et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem. 1996; 271;32529-32537.
65. Firth JD, Ebert BL, Pugh CW, Ratcliffe PJ. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer. Proc Natl Acad Sci U S A. 1994;91:6496-6500.
66. Ebert BL, Firth JD, Ratcliffe PJ. Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences. J Biol Chem. 1995;270:29083-29089.
67. Ebert BL, Gleadle JM, JF OR, Bartlett SM, Poulton J, Ratcliffe PJ. Isoenzyme-specitic regulation of genes involved in energy metabolism by hypoxia: similarities with the regulation of erythropoietin. Biochem J. 1996;313:809-814.
68. Minchenko A, Salceda S, Bauer T, Caro J. Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell Mol Biol Res. 1994;40:35-39.
69. Wang GL, Semenza GL. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A. 1993;90:4304-4308.
70. Maxwell PH, Pugh CW, Ratcliffe PJ. Inducible operation of the erythropoietin 3′ enhancer in multiple cell lines: evidence for a widespread oxygen-sensing mechanism. Proc Natl Acad Sci U S A. 1993;90:2423-2427.
71. Antequera F, Boyes J, Bird A. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell. 1990;62:503-514.
72. Wenger RH, Kvietikova I, Rolls A, Camenisch G, Gassmann M. Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site. Eur J Biochem. 1998;253:771-777.
73. Ingelbrecht I, Van Houdt H, Van Montagu M, Depicker A. Posttranscriptional silencing of reporter transgenes in tobacco correlates with DNA methylation . Proc Natl Acad Sci U S A. 1994;91: 10,502-10,506.
74. Toth M, Muller U, Doerfler W. Establishment of de novo DNA methylation patterns: transcription factor binding and deoxycytidine methylation at CpG and non-CpG sequences in an integrated adenovirus promoter. J Mol Biol. 1990;214:673-683.
75. Woodcock DM, Lawler CB, Linsenmeyer ME, Doherty JP, Warren WD. Asymmetric methylation in the hypermethylated CpG promoter region of the human L1 retrotransposon. J Biol Chem. 1997;272:7810-7816.